Lung diseases characterized by alveolar damage such as bronchopulmonary dysplasia (BPD) in premature infants and emphysema lack efficient treatments. Understanding the mechanisms contributing to normal and impaired alveolar growth and repair may identify new therapeutic targets for these lung diseases. Axonal guidance cues are molecules that guide the outgrowth of axons. Amongst these axonal guidance cues, members of the Semaphorin family, in particular Semaphorin 3C (Sema3C), contribute to early lung branching morphogenesis. The role of Sema3C during alveolar growth and repair is unknown. We hypothesized that Sema3C promotes alveolar development and repair. In vivo Sema3C knock down using intranasal siRNA during the postnatal stage of alveolar development in rats caused significant air space enlargement reminiscent of BPD. Sema3C knock down was associated with increased TLR3 expression and lung inflammatory cells influx. In a model of O 2 -induced arrested alveolar growth in newborn rats mimicking BPD, air space enlargement was associated with decreased lung Sema3C mRNA expression. In vitro, Sema3C treatment preserved alveolar epithelial cell viability in hyperoxia and accelerated alveolar epithelial cell wound healing. Sema3C preserved lung microvascular endothelial cell vascular network formation in vitro under hyperoxic conditions. In vivo, Sema3C treatment of hyperoxic rats decreased lung neutrophil influx and preserved alveolar and lung vascular growth. Sema3C also preserved lung plexinA2 and Sema3C expression, alveolar epithelial cell proliferation and decreased lung apoptosis. In conclusion, the axonal guidance cue Sema3C promotes normal alveolar growth and may be worthwhile further investigating as a potential therapeutic target for lung repair. 
Introduction
Bronchopulmonary dysplasia (BPD) in premature infants and emphysema represent a major health care challenge because of lack of efficient therapies [1, 2] . A common denominator of these diseases is the absence of injury resolution leading to distorted tissue repair and/or scarring resulting in arrested alveolar growth in BPD and alveolar destruction in emphysema [3] .
Understanding how alveoli and the underlying capillaries develop and how these mechanisms are disrupted in disease states are critical for developing effective therapies for lung diseases characterized by alveolar damage [4] .
Axonal guidance cues (AGC) are molecules that regulate neural network formation in the nervous system and the outgrowth of axons [5] . During development, specific connections between neurons and between neurons and their non-neuronal targets are determined in part by guidance molecules that allow neuronal growth cones to make selective pathway choices by providing both repulsive and attractive signals. Similar mechanisms may apply to the outgrowth of secondary crests that subdivide the sacculi into alveoli to increase the gas-exchange surface area during alveolar development [6] .
Among AGCs, members of the Semaphorin family, in particular class 3 semaphorins (Sema3), contribute to early lung branching morphogenesis. In early lung development, Sema3A is expressed mainly in the distal mesenchyme, Sema3C is expressed mainly in the large airway epithelium, and Sema3F is weakly expressed in both epithelium and mesenchyme [7, 8] . Functional assays suggest that Sema3 contribute to early lung development and have dual effects on branching morphogenesis in fetal lung explants. Exogenous Sema3A inhibits branching, while Sema3C and Sema3F enhance it. Later in gestation and after birth Sema3A is expressed in the terminal epithelium and mesenchyme and Sema3C and Sema3F are expressed in the distal epithelia. These expression profiles suggest that Sema3 signaling may contribute to alveolar development. But their role during this crucial period of lung development remains unexplored.
In addition, little is known about the role of Sema during tissue repair and the few available data derive from literature in the nervous system (reviewed in [9] ).
Here we show that: 1) Sema3C contributes to normal postnatal alveolar development because its inhibition leads to arrested alveolar growth; 2) Sema3C signaling is impaired in an experimental model of hyperoxia-induced arrested alveolar growth (mimicking features of BPD) in newborn rats; 3) in vitro, Sema3C treatment preserves lung alveolar epithelial cell (AEC) survival in hyperoxia, accelerates AEC wound healing and maintains the ability of lung microvascular endothelial cells to form vascular networks in hyperoxia; 4) in vivo, Sema3C treatment preserves alveolar growth in the hyperoxia-induced BPD model in newborn rats.
Materials and Methods
All procedures were approved by the Institutional Animal Care and Use Committee at the University of Alberta.
In vivo Sema3C Knock down using Small Interfering RNA (siRNA) Lung Sema3C was inhibited using intranasal Sema3c siRNA (Ambion, Austin, TX) administration (4 mg/g in 2.5 ml/g) [10] to rat pups at postnatal day (P) 4, 7, and 10 [10] [11] [12] [13] .
Immunoblotting
Protein expression in whole lungs was measured with immunoblotting as previously described [14] using commercially available antibodies.
Lung Morphometry
Lungs were inflated and fixed in situ via the trachea with a zinc formalin solution at a constant pressure of 20 cm H 2 O. After tracheal ligation lungs were removed and placed in fixative overnight, then processed and paraffin embedded. Five mm thick coronal sections were cut and stained with hematoxylin and eosin. Alveolar structures were quantified using the mean linear intercept methods as previously described [14, 15] .
Oxygen-induced Lung Injury
Experimental BPD was induced as previously described [14, 15] . Sprague-Dawley rats (Charles River, Saint Constant, QC, Canada) were exposed to normoxia (21% O 2 ) or hyperoxia (95% O 2 , BPD model) from birth to P14 in sealed plexiglass chambers with continuous O 2 monitoring (BioSpherix, Redfield, NY).
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
Whole lungs were analyzed by qRT-PCR using specific primers (Applied Biosystems, Foster City, CA) as previously described [14, 15] . Immunoblotting showing decreased whole lung Sema3C protein expression with intranasal Sema3C siRNA administration as compared to scrambled siRNA at P14 (n = 3 lungs/group, *P,0.05). C. Representative H&E-stained lung sections depicting alveolar simplification (fewer and larger alveoli with decreased secondary septa) reminiscent of BPD in Sema3C siRNA treated rat pups. D. Quantification of the mean linear intercept confirms arrested alveolar growth in Sema3C siRNA treated rat pups compared to scrambled siRNA (control) treated animals (n = 6 lungs/group, *P,0.05, Scale bar 130 mm). doi:10.1371/journal.pone.0067225.g001
Isolation and O 2 -exposure of Alveolar Epithelial Type 2 Cells (AEC2) Fetal day 19.5 rat lungs were removed and placed in serum-free DMEM on ice. The trachea was dissected away and the lungs were finely minced. The lung tissue was placed in a digestion solution containing 1 mg/mL Type V collagenase (Sigma, Oakville, ON, Canada) and 20 mg/mL DNase I at 37uC for 30 minutes. The supernatant was removed, centrifuged (5 minutes, 1500 RPM), and the cellular pellet resuspended in DMEM with serum. Fresh digestion solution was added to the remaining lung tissue, and this procedure was repeated until all tissue was digested. Collected cells were filtered through a 50 mm mesh, counted, and set to a concentration of 1.7610 6 cells/mL. Cells were seeded on to plastic tissue culture flasks for 45 minutes, after which the supernatant containing the AEC2 was collected and filtered through a 50 mm mesh. This differential plating step was repeated 3 more times to separate fibroblasts from AEC2s [15, 16] .
In Vitro AEC2 Cell Viability Assay
After 48 hrs of culture in normoxic (control) or hyperoxic conditions, cell viability was evaluated by measuring the mitochondrial-dependent reduction of colorless 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Invitrogen, Eugene, Oregon, USA) to a colored blue formazan which was dissolved in dimethyl sulfoxide and the absorbance of each sample was spectrophotometrically measured at 550 nm with a Spectra Max 190 (Molecular Devices) microplate reader as previously described [16] .
Wound Healing Assay with Fetal Rat AEC2
Freshly isolated AEC2 were seeded into a plastic 24-well cell culture plate, at a concentration of 10 6 cells/mL in DMEM (with 20% FBS and 1% PSF). At 36 hours, the cell monolayer was scraped with a p200 pipette tip and medium was replaced with DMEM or DMEM supplemented with Sema3C-FC chimera (R&D Systems) [360 ng/ml]. The surface area of the wound was recorded over time with OpenLab (Quorum Technologies Inc, Guelph, ON, Canada) [15] . 
Endothelial Network Formation Assay
The formation of cord-like structures by PMVEC was assessed by seeding 80,000 cells/well into 24-well plates coated with Matrigel (BD Biosciences, Mississauga, ON), supplemented with DMEM or DMEM supplemented with Sema3C-FC chimera (R&D Systems, Inc. Minneapolis, MN, USA) [360 ng/ml] and incubated at 37uC for 8 h in normoxia (21%) or hyperoxia (85%). Cord-like structures were observed using an inverted phase contrast microscope (Olympus, Melville, NY) and quantified by measuring the number of intersects and the length of structures in random fields from each well as described [14, 15] .
In vivo Sema3C Treatment
Sema3C (R&D Systems,) diluted in sterile distilled water was administered intraperitoneally [17] (25 mg/kg/day) from P4 to P14.
Immunohistochemistry
Paraffin sections (5 mm, coronal) from the right upper middle lobe (P14 Sema3C knockdown groups) or the left lung (P21 Sema3C treatment groups) were stained for CD68 (all groups) (1:250, ab125212, Abcam), Myeloperoxidase (MPO) (all groups) (1:500, ab45977, Abcam), Sema3C (Sema3C treated groups only) (1:50, NBP1-51281, Novus Biologicals), PlexinA2 (Sema3C treated groups only) (1:50, sc-25640, Santa Cruz Biotechnology), Myelin Basic Protein (MBP) (Sema3C treated groups only) (M3821, Sigma-Aldrich) and von Willebrand Factor (vWF) (Sema3C treated groups only) (1:200, A0082, Dako, Glostrup, Denmark). Briefly, sections were deparaffinized in an ethanol series. Antigen retrieval was performed by incubating slides in heated citrate buffer (10 mM pH 6.0) for 30 minutes, followed by blocking of endogenous peroxidase activity in 3% H 2 O 2 /PBS for 20 minutes. Non-specific binding was blocked by 30 minutes incubation with 10% Normal Goat Serum in 0.1% BSA/PBS at room temperature. Primary antibodies were diluted in 0.1% BSA/PBS and incubated with the sections overnight at 4uC. Subsequently, sections were rinsed in PBS and incubated with a biotinylated polyclonal goat-anti-rabbit IgG secondary antibody (1:200 in 0.1% BSA/PBS, E0432, Dako) for 1 hour at room temperature. The antibody signal was amplified by incubation with Vectastain Elite ABC reagent (PK-7100, Vector Laboratories, Burlingame, CA, USA) for 30 minutes and visualized with 3,39-Diaminobenzidine (DAB) staining. Tissue sections were counterstained with Mayer's hematoxylin, dehydrated in an ethanol series and coverslipped. For vWF staining, non-specific binding was blocked with TrisHCl/NaCl/BSA buffer and vWF antibody was diluted in Dako antibody diluent (S0809, Dako). After overnight incubation with vWF antibody, sections were incubated with biotinylated goatanti-rabbit IgG secondary antibody (1:1000, B2770, Invitrogen) diluted in Dako antibody diluent for 1 hour at room temperature. Antibody signal was amplified by incubation with streptavidin-HRP complex (1:1000 in Dako diluent; S911 Invitrogen) for 30 minutes at room temperature and visualized with DAB staining. Tissue sections were counterstained Mayer's hematoxylin, dehydrated in an ethanol series and coverslipped.
Sections were analyzed by light microscopy using a Zeiss (Imager.M2) microscope with Axiovision 4 software. All photomicrographs were taken at 200x magnification. Ki67 staining was semi-quantitatively scored by a blinded observer (AV) in three representative high-power fields per animal using the following system: 0 -no staining; 1 -light staining; 2 -medium staining; 3 -strong staining. CD68 and MPO positive cells were counted by a blinded observer (AV) using Image J software (Rasband, W.S., Image J US National Institutes of Health, Bethesda, Maryland, USA) in three representative high-power fields per animal and were subsequently averaged. vWF-positive vessels were counted by a blinded observer (AV) using Image J software in five representative high-power fields per animal and were subsequently averaged.
Statistics
Values are expressed as the mean6SEM. Statistical comparisons were made with the use of ANOVA. Post hoc analysis used a Fisher's probable least significant difference test (Statview 5.1, Abacus Concepts, Berkeley, CA). A value of P,0.05 was considered statistically significant. 
Results

Sema3C Inhibition Disrupts Normal Alveolar Development
Intranasal administration of Sema3C siRNA efficiently silenced total lung Sema3C protein expression in the neonatal rat lung compared to scrambled siRNA ( Figure 1A, B) .
Sema3C gene silencing during the critical period of alveolar development resulted in fewer and enlarged air spaces reminiscent of BPD ( Figure 1C ). Decreased alveolarization was confirmed by the mean linear intercept ( Figure 1D ). Scrambled siRNA had no effect on lung architecture.
Sema3C Inhibition Causes Lung Influx of CD68-and MPO-positive Cells
Sema3C siRNA led to a 3-fold increase of CD68 positive cells, a macrophage marker, when compared to control or scrambled siRNA exposed lungs (Figure 2A-B) . Similarly, there was a 4-fold increase in cells expressing neutrophil/monocyte myeloperoxidase ( Figure 2C-D) . This influx of inflammatory cells was associated with TLR3 up-regulation as compared with untreated and scrambled siRNA treated pups ( Figure 2E-F) .
Sema3C Expression is Developmentally Regulated during Normal Lung Growth and Impaired during O 2 -induced Arrested Alveolar Growth
Sema3C mRNA expression peaks during the canalicular stage of lung development and again during alveolar development (Figure 3 ). Sema3C expression is decreased at P14 towards the end of alveolar development in O 2 -induced experimental BPD.
Sema3C Protects AEC2 from O 2 -induced Toxicity and Accelerates Wound Healing
In vitro, the viability of freshly isolated AEC2, as assessed by the colorimetric MTT assay, was significantly decreased after 48 hours in 95%O 2 , as compared to room air cultured cells ( Figure 4A ). Recombinant Sema3C peptide significantly enhanced AEC2 survival in hyperoxia. In addition, Sema3C treatment accelerated AEC2 wound healing in an in vitro wound healing scratch assay by 30% compared to vehicle treated AEC2s (Figure 4B-C) .
Sema3C Preserves PMVEC Vascular Network Formation in Hyperoxia in vitro
Freshly isolated PMVECs were exposed to room air or 95% O 2 in serum-free Matrigel and assessed for the formation of vessel-like networks ( Figure 5A ). Hyperoxia significantly decreased endothelial cord-like structure formation, whereas Sema3C significantly 
Sema3C Treatment Preserves Alveolar and Lung Vascular Growth in O 2 -induced BPD
To test the therapeutic potential of Sema3C in vivo, neonatal rats exposed to hyperoxia for 14 days were treated with daily intraperitoneal injections of Sema3C. Hyperoxia induced a histological pattern reminiscent of human BPD, characterized by airspace enlargement with simplified and fewer alveolar structures as shown on representative H&E stained section ( Figure 6A ). Treatment with Sema3C from P4-P14 preserved alveolar development as quantified by the mean linear intercept ( Figure 6B ). Sema3C treatment had no adverse effects on lung architecture in control animals.
Hyperoxia also lead to an arrest in lung vascular growth as assessed by a decrease in vWF positive lung vessels ( Figure 7A-B) . Sema3C treatment attenuated the loss of vWF positive cells ( Figure 7A-B) .
Sema3C Attenuates Hyperoxia-induced Lung Influx of Inflammatory Cells
Hyperoxia exposure elicited an increase in CD68-positive cells (Figure 8 A-B) and MPO-positive cells (Figure 8C-D) . Sema3C treatment significantly attenuated the number of CD68-and MPO-positive cells in the lungs of hyperoxic-exposed animals.
Sema3C Attenuates Lung Apoptosis and Preserves Alveolar Epithelial Cell Proliferation
Hyperoxia exposure resulted in a 2-fold increase in caspase 3 protein levels compared to age-matched normoxia exposed controls ( Figure 9A-B) . Sema3C treatment significantly attenuated lung caspase 3 expression in hyperoxia. Sema3C had no effect on caspase 3 expression in room air housed rats. Hyperoxia significantly decreased Ki67 expression in alveolar epithelial cells compared to normoxic lungs ( Figure 9C-D) . Treatment with Sema3C preserved Ki67 expression in hyperoxia. Sema3C had no effect on Ki67 expression in control animals.
Sema3C Preserved Sema3C and PlexinA2 Expression
To further confirm that Sema3C had a direct impact on alveolar growth, we stained lung sections for Sema3C and for PlexinA2, a co-receptor specific for Sema3A and Sema3C [18] . Both PlexinA2 and Sema3C expression was significantly decreased in alveolar epithelial cells in hyperoxic rats (Figure 10A-B) . Sema3C preserved PlexinA2 expression in hyperoxia ( Figure 10A ). More intense Sema3C staining was seen in hyperoxic rats treated with Sema3C ( Figure 10B ). The density of myelinated nerves, as visualized by staining for myelin basic protein, was similar between groups ( Figure 10C ).
Discussion
We demonstrate that Sema3C is critical for normal alveolar growth and repair: in vivo Sema3C inhibition during the period of alveolar development arrests alveolar growth resulting in histological changes reminiscent of BPD. In experimental O 2 -induced BPD, arrested alveolar growth is associated with disrupted Sema3C signaling. Conversely, treatment with recombinant Sema3C protects AEC2 and PMVEC from O 2 toxicity and accelerates AEC2 wound healing in vitro. In vivo, Sema3C administration preserves alveolar growth. This observation suggests a lung protective effect of Sema3C.
The Axonal Guidance cue Sema3C Contributes to Normal Alveolar Development
In contrast to the large amount of information regarding the genetic control of the dichotomous division of the conducting airways in mammals, much less is known about the mechanisms that regulate alveolar development. During early branching morphogenesis, the conducting airways grow into the surrounding mesenchyme and many of the regulatory signaling molecules have been identified [19] . Conversely, alveolar septa evaginate inwards into the air space and the genetic control of alveolarization remains poorly understood [20] . One interesting theory is that a repulsive signal pushes the septa inward [6] . During development, specific connections between neurons and between neurons and their non-neuronal targets are determined in part by guidance molecules that allow neuronal growth cones to make selective pathway choices by providing both repulsive and attractive signals [5] . Adhesion receptors transduce the signals from the extracellular substrate to the cytoskeleton, thereby providing the traction necessary to move the growth cone, while guidance cues supply the directional information through attraction or repulsion [5] . Similar mechanisms may apply to the outgrowth of secondary septa during the formation of alveoli [6] . Thus AGCs are appealing candidates in guiding the growth of alveolar septa in the lung during alveolar development.
Sema3C knock out mice die within hours after birth because of cardiovascular defects [21] . In order to overcome early mortality to study the role of this AGC during postnatal alveolar development, we administered intranasal siRNA to neonatal rats to specifically silence lung Sema3C during the critical period of postnatal alveolar development. This strategy effectively silenced lung Sema3C and resulted in arrested alveolar growth. Our findings support the importance of class 3 Sema during postnatal lung development. Becker et al found that Sema3A 2/2 have increased perinatal mortality [22] . Interestingly, in lungs from the rare Sema3A 2/2 mice that survived the immediate perinatal period, alveolarization was markedly attenuated. In another study, loss of Sema3-Nrp1 signaling resulted in acute respiratory distress and high neonatal mortality [23] . The lungs of mutants were immature and displayed atelectasis, thickened alveolar septa, reduced capillary density, hypertensive changes in arteriolar walls, anomalous and misaligned pulmonary veins, and reduced pulmonary surfactant secretion. Together, these data provide evidence that class 3 Sema contribute to postnatal lung growth. Sema3C siRNA, but not scrambled siRNA, was associated with increased TLR3 expression and lung influx of inflammatory cells. Thus we cannot exclude that inflammation may also have contributed to the lung phenotype.
We provide additional evidence for the role of Sema3C during alveolar development by showing that Sema3C mRNA expression peaks during the late alveolar stage of lung development (P14). Conversely, Sema3C signaling is disrupted in O 2 -induced arrested alveolar growth: Sema3C mRNA expression is transiently decreased at P14 in hyperoxic-exposed rats compared to rat pups housed in room air. The role of class 3 Sema has also been explored in other lung disease models associated with distal airspace enlargement. Mice with lung-specific deletion of epithelial Nrp1 are more susceptible to cigarette smoke-induced lung injury [24] . Genetic deletion of epithelial Nrp1 in either postnatal or adult lungs resulted in a small increase in airspace size, but when challenged with cigarette smoke, both airspace enlargement and apoptosis of type I and type II alveolar epithelial cells were significantly enhanced in conditionally Nrp1-deficient adult mice. Altogether, these observations suggest that class 3 Sema promote normal alveolar development and are important for maintenance of alveolar homeostasis.
The axonal Guidance cue Sema3C Prevents Alveolar Damage
The findings above formed the rationale for testing the therapeutic potential of Sema3C to preserve normal alveolar development in a model of O 2 -induced arrested alveolar growth. The repair capabilities of Semaphorins remain relatively unexplored. Most data derive from the central nervous system. Expression studies of Sema3A after lesions of the olfactory nerve or bulbectomy suggest that Sema3A guides regenerating axons, but also contribute to the growth inhibitory characteristics of the scar region after lesions of axon tracts in the central nervous system [25, 26] . Using gain and loss of function experiments in an adult murine demyelination model, Piaton et al found that Sema3A impaired oligodendrocyte precursor cell recruitment to the demyelinated area [27] . In contrast, Sema3F overexpression accelerated oligodendrocyte precursor cell recruitment, and remyelination rate [27] . In a central corneal epithelial debridement model, the expression of Sema3A was markedly increased in basal cells of the newly healed corneal epithelium, and this upregulation of Sema3A was not associated with cell proliferation suggesting that Sema3A might play a role in the regulation of corneal epithelial wound healing [28] . Here we demonstrate for the first time, both in vitro and in vivo, that Sema3C treatment displays lung protective properties. In vitro, Sema3C preserved AEC2 viability in hyperoxia and accelerated AEC2 wound closure, suggesting that Sema3C promotes wound healing. Because angiogenesis contributes to alveolar growth [14] , we also demonstrate that Sema3C maintains PMVEC network formation in hyperoxia. This is consistent with observations that Sema3C enhances b 1 integrin function in endothelial cells by inducing its phosphorylation, VEGF 120 secretion and reduced endothelial cell apoptosis [29] .
To explore the therapeutic potential of Sema3C in vivo, we used the hyperoxic BPD model of lung injury, hypothesizing that Sema3C would preserve alveolarization. Consistent with our in vitro data, Sema3C preserved alveolar and vessel growth in hyperoxic-exposed pups, suggesting Sema3C as promising therapeutic target to prevent alveolar damage. This protective effect was associated with decreased lung neutrophil and macrophages accumulation, which significantly contribute to lung injury in BPD [30, 31] . We found that Sema3C treatment decreased both CD68 and MPO positive cells in lung sections compared to untreated hyperoxia rats. This observation is consistent with the growing evidence of ''immune semaphorins'' capable of modulating the inflammatory response [32] .
Our data indicate that in vivo sema3C stimulates proliferation and decreases apoptosis in our oxygen induced lung injury. These findings are consistent with previous studies indicating that Sema3C contributes to endothelial cell guidance, vascular morphogenesis and reduced apoptosis [29] . Also the typical histologic pattern of BPD is a combination of alveolar simplification and decreased pulmonary vessel density [33] . Our immunohistochemistry results using vWF showed that Sema3c treatment restores vessel density in hyperoxia rats. Ki67 is a nuclear protein that is expressed in all active phases (G1, S, G2, and M) of the cell cycle. Ki67 expression is required for cell proliferation and its expression correlates with the mitotic index [34] . Unlike proliferating cell nuclear antigen, Ki67 has a short half-life, which is an important consideration in developing lungs with a relatively high basal rate of cell proliferation. In our current study Sema3C treated lungs showed increased Ki67 expression compared to untreated hyperoxic animals. These findings suggest that the lower expression of Ki67 in hyperoxia might contribute to the arrest in lung growth. In vivo Sema3C treatment prevents O 2 -induced apoptosis and restores proliferation. A-B. Immunoblotting showed increased whole lung caspase 3 expression in hyperoxia exposed lungs, which was prevented by Sema3C treatment (n = 3/group, ****P,0.0001 hyperoxia vs. other groups). C. Representative photomicrographs showing Ki67 staining (brown) in RA (room air), RA+Sema3C, hyperoxia (O 2 ) and O 2 +Sema3C exposed lungs. Arrows highlight Ki67-positive cells; scale bars represent 100 mm. D. Ki67 staining intensity was significantly decreased compared to RA-exposed lungs, but was preserved by Sema3C treatment (n = 5-7/group, *P,0.05 Hyperoxia vs other groups). doi:10.1371/journal.pone.0067225.g009
In conclusion, we confirm that the AGC Sema3C is necessary for normal alveolar development. In addition, we show that Sema3C exerts therapeutic benefit in protecting the lung from O 2 -induced alveolar injury. Our findings suggest Sema3C as a molecule worthy of further evaluation as a putative target for lung repair.
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